SCHEMBL6717797

SCHEMBL6717797

O=C(O)Cc1cccc(-c2ccc(CC=NOCc3cccc(Cl)c3)cc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.42
ENPP2 Q13822 2/20 0.42
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
HTT P42858 2/20 0.40
ABCC4 O15439 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
TSHR P16473 1/20 0.40
PTGS1 P23219 1/20 0.40
TBXA2R P21731 1/20 0.40
PTGER1 P34995 1/20 0.40
SHMT1 P34896 1/20 0.40
SHMT2 P34897 1/20 0.40
FFAR1 O14842 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6717904 0.91 ENPP2 (0.50) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6719809 0.87 FFAR1 (0.43) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6718970 0.85 RXRA (0.47) FFAR1FFAR4RXRARXRBRXRG
SCHEMBL6715678 0.85 PTGDR2 (0.42) HCAR2GAATBXA2RPTGER1FFAR1
SCHEMBL6718854 0.84 AGXT (0.49) FFAR1RXRARXRBRXRGAGXT
SCHEMBL6717955 0.80 TBXA2R (0.42) ENPP2HTTGAATSHRTBXA2R
SCHEMBL3418693 0.78 NPC1 (0.61) SHMT1SHMT2RXRARXRBRXRG
SCHEMBL3418694 0.78 NPC1 (0.61) SHMT1SHMT2RXRARXRBRXRG
SCHEMBL2638114 0.76 S1PR1 (0.54) FFAR1FFAR4AKR1B1
SCHEMBL4208044 0.76 GRIN2D (0.55) ENPP2GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040214888-A1 Carboxylic acid derivative and medicine comprising salt or ester of the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040214888-A1 Carboxylic acid derivative and medicine comprising salt or ester of the same GPR119, NR3C1, INSR HCAR2 59/4885ENPP2 833/4885GRIN2D 280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.